The Advanced Integrated Respiratory (AIR) Model: Comparative Analysis of Salbutamol Sulphate Deposition from pMDI, DPI, and Nebuliser Versus the NGI
Pharmaceutical Research · 2026
DOI: 10.1007/s11095-026-04036-0 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Pharmaceutical Research, 2026. Verfasst von Patrick He und 8 weiteren Autor:innen. Beteiligte Einrichtung: Respiratory Technology, Woolcock Institute of Medical Research, Macquarie University, Sydney, NSW, Australia. Hauptthemen laut MEDLINE: Albuterol, Nebulizers and Vaporizers, Bronchodilator Agents. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council (NHMRC), Macquarie University.
Abstract (Originalsprache)
Purpose
In vitro respiratory models such as the Next Generation Impactor (NGI), remain the gold standard for aerodynamic particle size distribution (APSD) testing, however, they lack the anatomical complexity, limiting their ability to replicate in vivo deposition. To address this limitation, the Advanced Integrated Respiratory (AIR) model, a physiologically relevant benchtop system incorporating anatomically accurate silicone casts of the upper and lower airways, was used to assess deposition of salbutamol sulphate delivered via three clinically relevant platforms.
Methods
Salbutamol sulphate was delivered using a pressurised metered-dose inhaler (pMDI), a dry powder inhaler (DPI), and a jet nebuliser. Deposition profiles obtained in the AIR model were benchmarked against the NGI.
Results
Both systems showed consistent patterns for DPI and nebuliser aerosols, with highest deposition in the oropharyngeal and intrathoracic regions, respectively. In contrast, pMDI testing revealed important differences: the AIR model predicted markedly higher oropharyngeal retention and reduced intrathoracic delivery, aligning more closely with published in vivo scintigraphy studies than the NGI.
Conclusion
These findings demonstrate that anatomically realistic models provide critical insights into deposition behaviour, particularly for propellant driven inhalers and underscore the value of integrating physiologically relevant platforms alongside conventional impactors in aerosol characterisation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Respiratory Technology, Woolcock Institute of Medical Research, Macquarie University, Sydney, NSW, Australia.
- Defence Science and Technology Group, Fishermans Bend, VIC, Australia.
- School of Engineering, Macquarie University, Sydney, Australia.
- School of Chemical Engineering, University of New South Wales, Kensington, NSW, Australia.
- Macquarie Business School, Macquarie University, Sydney, NSW, Australia.
- Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia.
Förderung
- National Health and Medical Research Council (NHMRC)
- Macquarie University
Zitieren
APA
He, P., Lam, H., Chong, D., Cheng, S., Spicer, P., Young, P. M., Ledo, L., Traini, D., & Ong, H. X. (2026). The Advanced Integrated Respiratory (AIR) Model: Comparative Analysis of Salbutamol Sulphate Deposition from pMDI, DPI, and Nebuliser Versus the NGI. Pharmaceutical Research. https://doi.org/10.1007/s11095-026-04036-0
Vancouver
He P, Lam H, Chong D, Cheng S, Spicer P, Young PM, et al. The Advanced Integrated Respiratory (AIR) Model: Comparative Analysis of Salbutamol Sulphate Deposition from pMDI, DPI, and Nebuliser Versus the NGI. Pharmaceutical Research. 2026. doi:10.1007/s11095-026-04036-0
BibTeX
@article{He2026,
author = {He, Patrick and Lam, Hazel and Chong, Damien and Cheng, Shaokoon and Spicer, Patrick and Young, Paul Michael and Ledo, Lois and Traini, Daniela and Ong, Hui Xin},
title = {The Advanced Integrated Respiratory (AIR) Model: Comparative Analysis of Salbutamol Sulphate Deposition from pMDI, DPI, and Nebuliser Versus the NGI},
journal = {Pharmaceutical Research},
year = {2026},
doi = {10.1007/s11095-026-04036-0}
}
EUVIMED